Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis

Chiara Zingaretti, Milena Arigò, Angela Cardaci, Monica Moro, Mariacristina Crosti, Antonella Sinisi, Elisa Sugliano, Cristina Cheroni, Francesco Marabita, Renzo Nogarotto, Raoul Jean Pierre Bonnal, Paolo Marcatili, Maurizio Marconi, Annalinda Zignego, Paolo Muratori, Pietro Invernizzi, Piero Colombatto, Maurizia Brunetto, Ferruccio Bonino, Raffaele De FrancescoJens Geginat, Massimiliano Pagani, Luigi Muratori, Sergio Abrignani, Mauro Bombaci

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Autoimmune hepatitis (AIH) is an unresolving inflammation of the liver of unknown cause. Diagnosis requires the exclusion of other conditions and the presence of characteristic features such as specific autoantibodies. Presently, these autoantibodies have relatively low sensitivity and specificity and are identified via immunostaining of cells or tissues; therefore, there is a diagnostic need for better and easy-to-assess markers. To identify new AIH-specific autoantigens, we developed a protein microarray comprising 1626 human recombinant proteins, selected in silico for being secreted or membrane associated. We screened sera from AIH patients on this microarray and compared the reactivity with that of sera from healthy donors and patients with chronic viral hepatitis C. We identified six human proteins that are specifically recognized by AIH sera. Serum reactivity to a combination of four of these autoantigens allows identification of AIH patients with high sensitivity (82%) and specificity (92%). Of the six autoantigens, the interleukin-4 (IL4) receptor fibronectin type III domain of the IL4 receptor (CD124), which is expressed on the surface of both lymphocytes and hepatocytes, showed the highest individual sensitivity and specificity for AIH. Remarkably, patients' sera inhibited STAT6 phosphorylation induced by IL4 binding to CD124, demonstrating that these autoantibodies are functional and suggesting that IL4 neutralization has a pathogenetic role in AIH.

Original languageEnglish (US)
Pages (from-to)1885-1897
Number of pages13
JournalMolecular and Cellular Proteomics
Volume11
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Autoimmune Hepatitis
Protein Array Analysis
Autoantigens
Interleukin-4 Receptors
Interleukin-4
Autoantibodies
Microarrays
Phosphorylation
Proteins
Lymphocytes
Serum
Fibronectins
Recombinant Proteins
Liver
Sensitivity and Specificity
Tissue
Membranes
Chronic Hepatitis C
Computer Simulation
Hepatocytes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Cite this

Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. / Zingaretti, Chiara; Arigò, Milena; Cardaci, Angela; Moro, Monica; Crosti, Mariacristina; Sinisi, Antonella; Sugliano, Elisa; Cheroni, Cristina; Marabita, Francesco; Nogarotto, Renzo; Bonnal, Raoul Jean Pierre; Marcatili, Paolo; Marconi, Maurizio; Zignego, Annalinda; Muratori, Paolo; Invernizzi, Pietro; Colombatto, Piero; Brunetto, Maurizia; Bonino, Ferruccio; De Francesco, Raffaele; Geginat, Jens; Pagani, Massimiliano; Muratori, Luigi; Abrignani, Sergio; Bombaci, Mauro.

In: Molecular and Cellular Proteomics, Vol. 11, No. 12, 12.2012, p. 1885-1897.

Research output: Contribution to journalArticle

Zingaretti, C, Arigò, M, Cardaci, A, Moro, M, Crosti, M, Sinisi, A, Sugliano, E, Cheroni, C, Marabita, F, Nogarotto, R, Bonnal, RJP, Marcatili, P, Marconi, M, Zignego, A, Muratori, P, Invernizzi, P, Colombatto, P, Brunetto, M, Bonino, F, De Francesco, R, Geginat, J, Pagani, M, Muratori, L, Abrignani, S & Bombaci, M 2012, 'Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis', Molecular and Cellular Proteomics, vol. 11, no. 12, pp. 1885-1897. https://doi.org/10.1074/mcp.M112.018713
Zingaretti, Chiara ; Arigò, Milena ; Cardaci, Angela ; Moro, Monica ; Crosti, Mariacristina ; Sinisi, Antonella ; Sugliano, Elisa ; Cheroni, Cristina ; Marabita, Francesco ; Nogarotto, Renzo ; Bonnal, Raoul Jean Pierre ; Marcatili, Paolo ; Marconi, Maurizio ; Zignego, Annalinda ; Muratori, Paolo ; Invernizzi, Pietro ; Colombatto, Piero ; Brunetto, Maurizia ; Bonino, Ferruccio ; De Francesco, Raffaele ; Geginat, Jens ; Pagani, Massimiliano ; Muratori, Luigi ; Abrignani, Sergio ; Bombaci, Mauro. / Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. In: Molecular and Cellular Proteomics. 2012 ; Vol. 11, No. 12. pp. 1885-1897.
@article{b30400de8038490685010839b1275824,
title = "Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis",
abstract = "Autoimmune hepatitis (AIH) is an unresolving inflammation of the liver of unknown cause. Diagnosis requires the exclusion of other conditions and the presence of characteristic features such as specific autoantibodies. Presently, these autoantibodies have relatively low sensitivity and specificity and are identified via immunostaining of cells or tissues; therefore, there is a diagnostic need for better and easy-to-assess markers. To identify new AIH-specific autoantigens, we developed a protein microarray comprising 1626 human recombinant proteins, selected in silico for being secreted or membrane associated. We screened sera from AIH patients on this microarray and compared the reactivity with that of sera from healthy donors and patients with chronic viral hepatitis C. We identified six human proteins that are specifically recognized by AIH sera. Serum reactivity to a combination of four of these autoantigens allows identification of AIH patients with high sensitivity (82{\%}) and specificity (92{\%}). Of the six autoantigens, the interleukin-4 (IL4) receptor fibronectin type III domain of the IL4 receptor (CD124), which is expressed on the surface of both lymphocytes and hepatocytes, showed the highest individual sensitivity and specificity for AIH. Remarkably, patients' sera inhibited STAT6 phosphorylation induced by IL4 binding to CD124, demonstrating that these autoantibodies are functional and suggesting that IL4 neutralization has a pathogenetic role in AIH.",
author = "Chiara Zingaretti and Milena Arig{\`o} and Angela Cardaci and Monica Moro and Mariacristina Crosti and Antonella Sinisi and Elisa Sugliano and Cristina Cheroni and Francesco Marabita and Renzo Nogarotto and Bonnal, {Raoul Jean Pierre} and Paolo Marcatili and Maurizio Marconi and Annalinda Zignego and Paolo Muratori and Pietro Invernizzi and Piero Colombatto and Maurizia Brunetto and Ferruccio Bonino and {De Francesco}, Raffaele and Jens Geginat and Massimiliano Pagani and Luigi Muratori and Sergio Abrignani and Mauro Bombaci",
year = "2012",
month = "12",
doi = "10.1074/mcp.M112.018713",
language = "English (US)",
volume = "11",
pages = "1885--1897",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis

AU - Zingaretti, Chiara

AU - Arigò, Milena

AU - Cardaci, Angela

AU - Moro, Monica

AU - Crosti, Mariacristina

AU - Sinisi, Antonella

AU - Sugliano, Elisa

AU - Cheroni, Cristina

AU - Marabita, Francesco

AU - Nogarotto, Renzo

AU - Bonnal, Raoul Jean Pierre

AU - Marcatili, Paolo

AU - Marconi, Maurizio

AU - Zignego, Annalinda

AU - Muratori, Paolo

AU - Invernizzi, Pietro

AU - Colombatto, Piero

AU - Brunetto, Maurizia

AU - Bonino, Ferruccio

AU - De Francesco, Raffaele

AU - Geginat, Jens

AU - Pagani, Massimiliano

AU - Muratori, Luigi

AU - Abrignani, Sergio

AU - Bombaci, Mauro

PY - 2012/12

Y1 - 2012/12

N2 - Autoimmune hepatitis (AIH) is an unresolving inflammation of the liver of unknown cause. Diagnosis requires the exclusion of other conditions and the presence of characteristic features such as specific autoantibodies. Presently, these autoantibodies have relatively low sensitivity and specificity and are identified via immunostaining of cells or tissues; therefore, there is a diagnostic need for better and easy-to-assess markers. To identify new AIH-specific autoantigens, we developed a protein microarray comprising 1626 human recombinant proteins, selected in silico for being secreted or membrane associated. We screened sera from AIH patients on this microarray and compared the reactivity with that of sera from healthy donors and patients with chronic viral hepatitis C. We identified six human proteins that are specifically recognized by AIH sera. Serum reactivity to a combination of four of these autoantigens allows identification of AIH patients with high sensitivity (82%) and specificity (92%). Of the six autoantigens, the interleukin-4 (IL4) receptor fibronectin type III domain of the IL4 receptor (CD124), which is expressed on the surface of both lymphocytes and hepatocytes, showed the highest individual sensitivity and specificity for AIH. Remarkably, patients' sera inhibited STAT6 phosphorylation induced by IL4 binding to CD124, demonstrating that these autoantibodies are functional and suggesting that IL4 neutralization has a pathogenetic role in AIH.

AB - Autoimmune hepatitis (AIH) is an unresolving inflammation of the liver of unknown cause. Diagnosis requires the exclusion of other conditions and the presence of characteristic features such as specific autoantibodies. Presently, these autoantibodies have relatively low sensitivity and specificity and are identified via immunostaining of cells or tissues; therefore, there is a diagnostic need for better and easy-to-assess markers. To identify new AIH-specific autoantigens, we developed a protein microarray comprising 1626 human recombinant proteins, selected in silico for being secreted or membrane associated. We screened sera from AIH patients on this microarray and compared the reactivity with that of sera from healthy donors and patients with chronic viral hepatitis C. We identified six human proteins that are specifically recognized by AIH sera. Serum reactivity to a combination of four of these autoantigens allows identification of AIH patients with high sensitivity (82%) and specificity (92%). Of the six autoantigens, the interleukin-4 (IL4) receptor fibronectin type III domain of the IL4 receptor (CD124), which is expressed on the surface of both lymphocytes and hepatocytes, showed the highest individual sensitivity and specificity for AIH. Remarkably, patients' sera inhibited STAT6 phosphorylation induced by IL4 binding to CD124, demonstrating that these autoantibodies are functional and suggesting that IL4 neutralization has a pathogenetic role in AIH.

UR - http://www.scopus.com/inward/record.url?scp=84870713369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870713369&partnerID=8YFLogxK

U2 - 10.1074/mcp.M112.018713

DO - 10.1074/mcp.M112.018713

M3 - Article

C2 - 22997428

AN - SCOPUS:84870713369

VL - 11

SP - 1885

EP - 1897

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 12

ER -